Anesthesia

Assure Holdings Enters Into Commitments To Receive Approximately US$10 Million From Institutional Investors

Monday, November 30, 2020 - 10:30pm

Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of USD$0.78 for a period of 5 years from the date of issuance.

Key Points: 
  • Each Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of USD$0.78 for a period of 5 years from the date of issuance.
  • In connection with the Offering, the Company anticipates paying fees of approximately US$940,000.
  • Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries.
  • Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commissions Gold Seal of Approval.

Innovations and Growth Opportunities in Blood Gas Analyzer, Point of Care Testing, Wound Care, Diabetes Management, and Sleep Monitoring Solutions, 2020 Market Report - ResearchAndMarkets.com

Monday, November 30, 2020 - 4:44pm

The "Innovations and Growth Opportunities in Blood Gas Analyzer, Point of Care Testing, Wound Care, Diabetes Management, and Sleep Monitoring Solutions" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Innovations and Growth Opportunities in Blood Gas Analyzer, Point of Care Testing, Wound Care, Diabetes Management, and Sleep Monitoring Solutions" report has been added to ResearchAndMarkets.com's offering.
  • The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices and diagnostic industry.
  • In addition, innovations such as smart patch for diabetes management, oxygen-based wound therapy and sleep monitoring solutions are also covered.
  • These innovations portray the diversity in their technology readiness levels, indicating an immediate or potential market impact.

$713 Million Capnography Devices Markets - Global Industry Analysis and Growth Forecast to 2030 - ResearchAndMarkets.com

Monday, November 30, 2020 - 10:14am

The "Capnography Devices Market Research Report: By Product, Technology, Component, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Capnography Devices Market Research Report: By Product, Technology, Component, Application, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global capnography devices market reached a valuation of $379.9 million in 2019 and is expected to advance at a CAGR of 6.0% between 2020 and 2030 and generate a revenue of $713.3 million in 2030.
  • This is credited to the rising incidence of respiratory diseases, rapid technological innovations in capnography devices, and the increasing implementation of government policies in this niche.
  • The soaring implementation of government initiatives in several countries is another major factor fueling the expansion of the capnography devices market.

Sedana Medical submits market approval application for the drug Sedaconda

Friday, November 27, 2020 - 11:59am

STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care.

Key Points: 
  • STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care.
  • The application is the starting point of the review process of Sedaconda in 15 of the EU member states, including Norway.
  • If all goes well, Sedana Medical expects an approval in the second half of 2021.
  • The market approval application is based on the strong results in Sedana Medical's pivotal phase III study, SED-001.

Sedana Medical submits market approval application for the drug Sedaconda

Friday, November 27, 2020 - 11:57am

STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care.

Key Points: 
  • STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care.
  • The application is the starting point of the review process of Sedaconda in 15 of the EU member states, including Norway.
  • If all goes well, Sedana Medical expects an approval in the second half of 2021.
  • The market approval application is based on the strong results in Sedana Medical's pivotal phase III study, SED-001.

The Worldwide Patient Monitoring Devices Industry is Expected to Reach $55.1 Billion by 2025

Thursday, November 26, 2020 - 10:15pm

6 Patient Monitoring Devices Market, by Product

Key Points: 

6 Patient Monitoring Devices Market, by Product
6.5.4.1 Extensive Research in Capnography Has Led to the Development of Improved Capnographs, Resulting in Their Increased Commercial Acceptance
7 Patient Monitoring Devices Market, by End-user
8 Patient Monitoring Devices Market, by Region

Global Hemodynamic Monitoring Systems Market 2020-2025 - Technology Innovations and Evolving Standard of Care Fueling Growth - ResearchAndMarkets.com

Thursday, November 26, 2020 - 2:10pm

The "Technology Innovations and Evolving Standard of Care Fueling Growth of the Global Hemodynamic Monitoring Systems Market, 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Technology Innovations and Evolving Standard of Care Fueling Growth of the Global Hemodynamic Monitoring Systems Market, 2025" report has been added to ResearchAndMarkets.com's offering.
  • Hemodynamic monitoring aims to guide medical management of critically ill patients who are prone to hemodynamic instability.
  • This study aims to analyze and forecast the market outlook for hemodynamic monitoring systems in North America, European Union (EU), and Asia-Pacific (APAC).
  • It profiles major companies in the hemodynamic monitoring systems market and provides recommendations on growth opportunities.

Global Laryngoscopes Market | Forecasting Strategy to Undergo a Paradigm Shift From Crisis to New Normal During COVID-19 Pandemic | Technavio

Wednesday, November 25, 2020 - 2:30pm

The laryngoscopes market is poised to grow by USD 357.20 million during 2020-2024, progressing at a CAGR of almost 13% during the forecast period.

Key Points: 
  • The laryngoscopes market is poised to grow by USD 357.20 million during 2020-2024, progressing at a CAGR of almost 13% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201125005365/en/
    Technavio has announced its latest market research report titled Global Laryngoscopes Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your Business?
  • The report on the laryngoscopes market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment.

Global Critical Care Patient Monitoring Market Report 2020: Analysis of the Major Shift in Critical Care Patient Monitoring from Stand-Alone Monitor to Integrated Solution Offerings - ResearchAndMarkets.com

Wednesday, November 25, 2020 - 11:53am

The "Global Critical Care Patient Monitoring Market, 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Critical Care Patient Monitoring Market, 2020" report has been added to ResearchAndMarkets.com's offering.
  • The ICU is the most data-intensive part of the hospital, as continuous monitoring of patient health generates a huge volume of crucial data valuable for clinical decision making and future research.
  • The shift from fee-for-service to value-based care has been responsible for further driving the adoption of monitoring solutions that not only improve health outcomes but also care quality.
  • An analysis of the major shift in critical care patient monitoring (CCPM) - from stand-alone monitor to integrated solution offerings inclusive of data management, wireless monitoring, teleICU, and others - and more than 80 ecosystem players with diverse solution capabilities helped the publisher identify 15 market leaders to be plotted on their report for the CCPM market.

Assure to Attend Investor Conferences in December 2020

Wednesday, November 25, 2020 - 12:00am

DENVER, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that management will participate in the following investor conferences in December 2020:

Key Points: 
  • DENVER, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the Company or Assure) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that management will participate in the following investor conferences in December 2020:
    Diamond Equity Research Emerging Growth Invitational on December 1, 2020.
  • Assures executive chairman and CEO John Farlinger is scheduled to present on December 1st at 1:00 p.m.
  • Register for the webcast here: https://us02web.zoom.us/webinar/register/WN_KuHurFdvRh2Y_jOQJe8sYg
    Lytham Partners Virtual Investor Growth Conference on December 7-11, 2020.
  • Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commissions Gold Seal of Approval.